Tiger Pharmaceuticals (03347) issued an announcement. The company's board of directors meeting reviewed and approved the “On Adjusting the Company's Share Repurchase Plan...
Zhitong Finance App News, Tiger Pharmaceuticals (03347) issued an announcement. The company's board of directors reviewed and passed the “Proposal on Adjusting the Company's Share Repurchase Plan”. According to the current capital market and the actual situation of the company, in order to further boost investor confidence and ensure the smooth implementation of the company's share repurchase plan, the board of directors of the company agreed to adjust the share repurchase plan: the share repurchase price was adjusted from “no more than RMB 60.00 per share (including 60.00 yuan/share)” to “no more than RMB 72.00 per share (including 72.00 yuan/share)”; the total amount of shares repurchased remained unchanged, to be no less than RMB 500 million and no more than RMB 1 billion, according to the upper limit of the adjusted repurchase price.